Literature DB >> 29317550

Fertility-Sparing Treatment of Endometrial Cancer with Initial Infiltration of Myometrium by Resectoscopic Surgery: A Pilot Study.

Paolo Casadio1, Francesca Guasina1, Roberto Paradisi2, Concetta Leggieri1, Giacomo Caprara3, Renato Seracchioli1.   

Abstract

Three women with a well-differentiated grade 1 endometrioid adenocarcinoma of the endometrium with minimal myometrial infiltration were treated with hysteroscopic resection and hormone therapy. The presence of myometrial infiltration has often been mentioned as an exclusion criterion for conservative management in young patients because of worsening cancer prognosis. The subsequent 5-year follow-up and the pregnancies achieved may confirm the choice of this temporary treatment and indicate a new option for fertility-sparing treatment in highly motivated patients. © AlphaMed Press 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29317550      PMCID: PMC5896712          DOI: 10.1634/theoncologist.2017-0285

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  11 in total

1.  Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Authors:  W T Creasman; F Odicino; P Maisonneuve; M A Quinn; U Beller; J L Benedet; A P M Heintz; H Y S Ngan; S Pecorelli
Journal:  Int J Gynaecol Obstet       Date:  2006-11       Impact factor: 3.561

2.  A retrospective review of magnetic resonance imaging in assessing the extent of myometrial infiltration for patients with endometrial carcinoma.

Authors:  G C Rieck; J Bulman; R Whitaker; S C Leeson
Journal:  J Obstet Gynaecol       Date:  2005-11       Impact factor: 1.246

Review 3.  Sparing fertility in young patients with endometrial cancer.

Authors:  Luis Chiva; Fernando Lapuente; Lucia González-Cortijo; Natalia Carballo; Juan F García; Alejandro Rojo; Antonio Gonzalez-Martín
Journal:  Gynecol Oncol       Date:  2008-09-18       Impact factor: 5.482

4.  Endometrioid adenocarcinoma treated by hysteroscopic endomyometrial resection.

Authors:  George A Vilos; Helen C Ettler; Fawaz Edris; Jackie Hollett-Caines; Basim Abu-Rafea
Journal:  J Minim Invasive Gynecol       Date:  2007 Jan-Feb       Impact factor: 4.137

5.  Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection.

Authors:  I Mazzon; G Corrado; D Morricone; G Scambia
Journal:  Int J Gynecol Cancer       Date:  2005 Sep-Oct       Impact factor: 3.437

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 7.  Innovations in fertility preservation for patients with gynecologic cancers.

Authors:  Wen-Shiung Liou; O W Stephanie Yap; John K Chan; Lynn M Westphal
Journal:  Fertil Steril       Date:  2005-12       Impact factor: 7.329

8.  Conservative surgical management of stage IA endometrial carcinoma for fertility preservation.

Authors:  Ivan Mazzon; Giacomo Corrado; Valeria Masciullo; Daniela Morricone; Gabriella Ferrandina; Giovanni Scambia
Journal:  Fertil Steril       Date:  2009-08-22       Impact factor: 7.329

9.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.

Authors:  N Colombo; C Creutzberg; F Amant; T Bosse; A González-Martín; J Ledermann; C Marth; R Nout; D Querleu; M R Mirza; C Sessa
Journal:  Ann Oncol       Date:  2015-12-02       Impact factor: 32.976

10.  Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.

Authors:  Francesca Falcone; Giuseppe Laurelli; Simona Losito; Marilena Di Napoli; Vincenza Granata; Stefano Greggi
Journal:  J Gynecol Oncol       Date:  2016-08-08       Impact factor: 4.401

View more
  10 in total

1.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

2.  Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study.

Authors:  Paolo Casadio; Francesca Guasina; Maria Rita Talamo; Roberto Paradisi; Ciro Morra; Giulia Magnarelli; Renato Seracchioli
Journal:  J Gynecol Oncol       Date:  2019-04-22       Impact factor: 4.401

Review 3.  The Perspectives of Fertility Preservation in Women with Endometrial Cancer.

Authors:  Jure Knez; Leyla Al Mahdawi; Iztok Takač; Monika Sobočan
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

4.  Fertility-sparing treatment in women with endometrial cancer.

Authors:  Seyeon Won; Mi Kyoung Kim; Seok Ju Seong
Journal:  Clin Exp Reprod Med       Date:  2020-11-10

Review 5.  Conservative Surgery in Endometrial Cancer.

Authors:  Alessandra Gallo; Ursula Catena; Gabriele Saccone; Attilio Di Spiezio Sardo
Journal:  J Clin Med       Date:  2021-12-29       Impact factor: 4.241

6.  Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy.

Authors:  Junyu Chen; Dongyan Cao; Jiaxin Yang; Mei Yu; Huimei Zhou; Ninghai Cheng; Jinhui Wang; Ying Zhang; Peng Peng; Keng Shen
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

7.  Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.

Authors:  Erica Herrera Cappelletti; Jonas Humann; Rafael Torrejón; Pietro Gambadauro
Journal:  Hum Reprod Update       Date:  2022-02-28       Impact factor: 15.610

8.  Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma.

Authors:  Chu-Yu Jing; Sheng-Nan Li; Bo-Er Shan; Wei Zhang; Wen-Juan Tian; Yu-Lan Ren; Hua-Ying Wang
Journal:  Clin Med Insights Oncol       Date:  2022-07-18

9.  Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer.

Authors:  Carlo Ronsini; Lavinia Mosca; Irene Iavarone; Roberta Nicoletti; Davide Vinci; Raffaela Maria Carotenuto; Francesca Pasanisi; Maria Cristina Solazzo; Pasquale De Franciscis; Marco Torella; Marco La Verde; Nicola Colacurci; Luigi Cobellis; Giuseppe Vizzielli; Stefano Restaino
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

Review 10.  New Insights into Endometrial Cancer.

Authors:  Laura Paleari; Silvia Pesce; Mariangela Rutigliani; Marco Greppi; Valentina Obino; Franco Gorlero; Valerio Gaetano Vellone; Emanuela Marcenaro
Journal:  Cancers (Basel)       Date:  2021-03-24       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.